Text Size
1 study found for:    GX15-070 AND myeloma

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
1 Active, not recruiting Obatoclax and Bortezomib in Treating Patients With Relapsed or Refractory Multiple Myeloma
Conditions: Refractory Multiple Myeloma;   Stage I Multiple Myeloma;   Stage II Multiple Myeloma;   Stage III Multiple Myeloma
Interventions: Drug: obatoclax mesylate;   Other: laboratory biomarker analysis;   Genetic: gene expression analysis;   Genetic: microarray analysis;   Drug: bortezomib
To Top

† Indicates status has not been verified in more than two years